Drug intelligence / Profile preview

CAP UnScented

Development stage: Preclinical
Lead developer: HALEON
Modality: Small Molecules
Administration: Topical

Overview

CAP UnScented is a sunscreen lip balm developed by HALEON. It is designed to provide 80-minute water-resistant sun protection, with its efficacy evaluated according to the FDA Final Rule for Sunscreen Drug Products (2011). As a sunscreen, its primary function is to protect the lips from harmful ultraviolet (UV) radiation.

Brand names: CAP UnScentedChapStick Active Performance UnScented
Other names: ChapStick Active Performance Unscented Lip Balm

Beyond the preview

Go deeper on CAP UnScented.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAP UnScented.

Explore the full profile